When was MOgene founded?

MOgene was founded in 2004 and raised its 1st funding round 7 years after it was founded.

Where is MOgene located?

MOgene is headquartered in St. Louis, United States.

How many employees does MOgene have?

As of Jul 01, 2024, the latest employee count at MOgene is 10.

Is MOgene a funded company?

MOgene is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Nov 15, 2011.

When was the latest funding round of MOgene?

MOgene's latest funding was a $***** Grant (prize money) round on Sep 30, 2013, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $710M in funding in 2026 to date.

Where does MOgene rank among its competitors?

MOgene ranks 112th amongst 588 active competitors, of which 59 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ONCOHOST, which secured $2.8M in May, 2025.

Who are the top competitors of MOgene?

MOgene's top competitors include Strand Life Sciences, Novogene Corporation and ONCOHOST. Among them, ONCOHOST secured the most recent funding round in May, 2025.

MOgene - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of comprehensive genomics services for industrial research groups and institutions. The company offers the following services Sequencing, next-generation sequencing, array and assay development, immune assays, genotyping services, real-time PCR. It is a CLIA certified genomics company.

Website: mogene.com
Social
Email ID: *****@mogene.com
Phone Number: +1 **********

Key Metrics

Founded Year

2004

Location

St. Louis, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Sep 30, 2013, $*****

Investors

National Science Foundation

Ranked

112^th among 588 active competitors

Employee Count

10 as on Jul 01, 2024

Similar Companies

Strand Life Sciences & 823 more

View MOgene's full profile

MOgene has raised funding over 2 rounds. Its first funding round was on Nov 15, 2011. MOgene has 1 institutional investor.

Here is the list of recent funding rounds of MOgene:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 30, 2013	9791451	Grant (prize money)	9418701	2278329	4821800	8106582
Nov 15, 2011	8012684	Grant (prize money)	3284289	3955744	9492021	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of MOgene's funding rounds and investors

The founders of MOgene is Ralph Quatrano.

Here are the details of MOgene's key team members:

Ralph Quatrano: Founder of MOgene.

View details of MOgene's Founder profiles and Board Members

MOgene's employee count trend

MOgene has 10 employees as of Jul 24. Here is MOgene's employee count trend over the years:

Uncover MOgene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MOgene include Strand Life Sciences, Novogene Corporation and ONCOHOST. Here is the list of Top 10 competitors of MOgene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 91 others	64/100
2nd	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	61/100
3rd	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	OurCrowd, ALIVE & 5 others	61/100
4th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Kenson Ventures, Orbimed & 5 others	59/100
5th	deCODE Genetics 1996, Reykjavik (Iceland), Acquired	Provider of a bioinformatics platform for genetic analysis	-	Polaris Partners, Tekla Capital Management ... & 10 others	59/100
6th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Fusion Capital, Sequoia Capital China & 15 others	54/100
7th	Source BioScience 1903, Nottingham (United Kingdom), Acquired	Provider of multiple genomic services	-	HPE	54/100
8th	Tavotek 2018, King Of Prussia (United States), Series B	Provider of drug discovery platform for different diseases	$35M	Yuanbio Venture Capital, GF Xinde Investment Management ... & 6 others	54/100
9th	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	SV Health Investors, M Ventures & 36 others	53/100
10th	Malaysian Genomics Resource Centre 2004, Kuala Lumpur (Malaysia), Acquired	Provider of genome sequencing, analysis, and genetic screening services	-	FirstFloor Capital, Singularity Ventures & 1 others	53/100
112th	MOgene 2004, St. Louis (United States), Funding Raised	Provider of comprehensive genomics services for industrial research groups and institutions	-	National Science Foundation	32/100